FDA expands authorization for Pfizer’s Covid-19 booster to cover 16- and 17-year-olds
The Food and Drug Administration on Thursday expanded the emergency use authorization for Pfizer and BioNTech’s Covid-19 booster shot to cover 16- and 17-year-olds, making it the only booster shot currently available in the United States for teenagers in this age group.
The move to make the shots available to them comes at a time when the Biden administration is trying to increase uptake of booster shots to build up immunity to battle a surge in Delta variant cases and a feared winter wave of infections potentially caused by the new and highly transmissible Omicron variant.
